S-adenosyl-L-methionine: Transcellular transport and uptake by Caco-2 cells and hepatocytes

J. M. McMillan, U. K. Walle, T. Walle

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

S-adenosyl-L-methionine (SAMe) is an endogenous molecule that is known to be protective against hepatotoxic injury. Although oral SAMe appears to be absorbed across the intestinal mucosa, its systemic bioavailability is low. The reason for this is unknown. Using the Caco-2 cell culture model for enterocyte absorption, we determined the mode by which SAMe is transported across this cell monolayer. We also determined the extent it is taken up by both Caco-2 cells and hepatocytes. In Caco-2 cells transport was observed in both apical to basolateral and basolateral to apical directions. The apparent permeability coefficients (Papp) appeared to be concentration independent and were similar in both directions (0.7 × 10-6 and 0.6 × 10 -6 cms-1, respectively), i.e. identical to that of the paracellular transport marker mannitol (0.9 × 10-6 and 0.7 × 10-6 cms-1). This mode of transport was supported by a four-fold increase in the Papp for SAMe transport in Ca ++-free buffer. Cellular uptake of SAMe was examined in both Caco-2 cells and cultured rat hepatocytes. Uptake by hepatocytes was not saturable in a concentration range of 0.001-100 μM. Accumulation by both cell types was very low, with a cell:medium ratio at equilibrium of only 0.2-0.5. This low cell accumulation supports the finding of paracellular transport as the only mode of cell membrane transport. Increased hepatocellular protection for SAMe may be accomplished by converting SAMe to a more lipid-soluble prodrug.

Original languageEnglish (US)
Pages (from-to)599-605
Number of pages7
JournalJournal of Pharmacy and Pharmacology
Volume57
Issue number5
DOIs
StatePublished - May 1 2005

Fingerprint

Transcytosis
S-Adenosylmethionine
Caco-2 Cells
Hepatocytes
Enterocytes
Prodrugs
Mannitol
Intestinal Mucosa
Biological Availability
Permeability
Buffers
Cell Culture Techniques
Cell Membrane
Lipids
Wounds and Injuries

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

S-adenosyl-L-methionine : Transcellular transport and uptake by Caco-2 cells and hepatocytes. / McMillan, J. M.; Walle, U. K.; Walle, T.

In: Journal of Pharmacy and Pharmacology, Vol. 57, No. 5, 01.05.2005, p. 599-605.

Research output: Contribution to journalArticle

@article{7e6c0963c73742459ae08d8562715080,
title = "S-adenosyl-L-methionine: Transcellular transport and uptake by Caco-2 cells and hepatocytes",
abstract = "S-adenosyl-L-methionine (SAMe) is an endogenous molecule that is known to be protective against hepatotoxic injury. Although oral SAMe appears to be absorbed across the intestinal mucosa, its systemic bioavailability is low. The reason for this is unknown. Using the Caco-2 cell culture model for enterocyte absorption, we determined the mode by which SAMe is transported across this cell monolayer. We also determined the extent it is taken up by both Caco-2 cells and hepatocytes. In Caco-2 cells transport was observed in both apical to basolateral and basolateral to apical directions. The apparent permeability coefficients (Papp) appeared to be concentration independent and were similar in both directions (0.7 × 10-6 and 0.6 × 10 -6 cms-1, respectively), i.e. identical to that of the paracellular transport marker mannitol (0.9 × 10-6 and 0.7 × 10-6 cms-1). This mode of transport was supported by a four-fold increase in the Papp for SAMe transport in Ca ++-free buffer. Cellular uptake of SAMe was examined in both Caco-2 cells and cultured rat hepatocytes. Uptake by hepatocytes was not saturable in a concentration range of 0.001-100 μM. Accumulation by both cell types was very low, with a cell:medium ratio at equilibrium of only 0.2-0.5. This low cell accumulation supports the finding of paracellular transport as the only mode of cell membrane transport. Increased hepatocellular protection for SAMe may be accomplished by converting SAMe to a more lipid-soluble prodrug.",
author = "McMillan, {J. M.} and Walle, {U. K.} and T. Walle",
year = "2005",
month = "5",
day = "1",
doi = "10.1211/0022357056082",
language = "English (US)",
volume = "57",
pages = "599--605",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "5",

}

TY - JOUR

T1 - S-adenosyl-L-methionine

T2 - Transcellular transport and uptake by Caco-2 cells and hepatocytes

AU - McMillan, J. M.

AU - Walle, U. K.

AU - Walle, T.

PY - 2005/5/1

Y1 - 2005/5/1

N2 - S-adenosyl-L-methionine (SAMe) is an endogenous molecule that is known to be protective against hepatotoxic injury. Although oral SAMe appears to be absorbed across the intestinal mucosa, its systemic bioavailability is low. The reason for this is unknown. Using the Caco-2 cell culture model for enterocyte absorption, we determined the mode by which SAMe is transported across this cell monolayer. We also determined the extent it is taken up by both Caco-2 cells and hepatocytes. In Caco-2 cells transport was observed in both apical to basolateral and basolateral to apical directions. The apparent permeability coefficients (Papp) appeared to be concentration independent and were similar in both directions (0.7 × 10-6 and 0.6 × 10 -6 cms-1, respectively), i.e. identical to that of the paracellular transport marker mannitol (0.9 × 10-6 and 0.7 × 10-6 cms-1). This mode of transport was supported by a four-fold increase in the Papp for SAMe transport in Ca ++-free buffer. Cellular uptake of SAMe was examined in both Caco-2 cells and cultured rat hepatocytes. Uptake by hepatocytes was not saturable in a concentration range of 0.001-100 μM. Accumulation by both cell types was very low, with a cell:medium ratio at equilibrium of only 0.2-0.5. This low cell accumulation supports the finding of paracellular transport as the only mode of cell membrane transport. Increased hepatocellular protection for SAMe may be accomplished by converting SAMe to a more lipid-soluble prodrug.

AB - S-adenosyl-L-methionine (SAMe) is an endogenous molecule that is known to be protective against hepatotoxic injury. Although oral SAMe appears to be absorbed across the intestinal mucosa, its systemic bioavailability is low. The reason for this is unknown. Using the Caco-2 cell culture model for enterocyte absorption, we determined the mode by which SAMe is transported across this cell monolayer. We also determined the extent it is taken up by both Caco-2 cells and hepatocytes. In Caco-2 cells transport was observed in both apical to basolateral and basolateral to apical directions. The apparent permeability coefficients (Papp) appeared to be concentration independent and were similar in both directions (0.7 × 10-6 and 0.6 × 10 -6 cms-1, respectively), i.e. identical to that of the paracellular transport marker mannitol (0.9 × 10-6 and 0.7 × 10-6 cms-1). This mode of transport was supported by a four-fold increase in the Papp for SAMe transport in Ca ++-free buffer. Cellular uptake of SAMe was examined in both Caco-2 cells and cultured rat hepatocytes. Uptake by hepatocytes was not saturable in a concentration range of 0.001-100 μM. Accumulation by both cell types was very low, with a cell:medium ratio at equilibrium of only 0.2-0.5. This low cell accumulation supports the finding of paracellular transport as the only mode of cell membrane transport. Increased hepatocellular protection for SAMe may be accomplished by converting SAMe to a more lipid-soluble prodrug.

UR - http://www.scopus.com/inward/record.url?scp=17644382927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644382927&partnerID=8YFLogxK

U2 - 10.1211/0022357056082

DO - 10.1211/0022357056082

M3 - Article

C2 - 15901349

AN - SCOPUS:17644382927

VL - 57

SP - 599

EP - 605

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 5

ER -